MDMA/LSD - monoamine oxidase transporters Flashcards
5-HT
serotonin
most 5-HT receptors are
metabotropic/GPCRs
only 5HT3 ionotropic
what is different about 5-HT3 receptor
ionotropic
activation of Gq coupled 5HT receptors
leads to hydrolysis of membrane phosphoinositides
increased DAG and IP3
activation of PKC
increased intracellular Ca2+
activation of Gs coupled 5HT receptors
stimulates adenyl cyclase
increased cAMP
activation of PKA
activation of Gi/o coupled 5HT receptors
inhibition of adenyl cyclase
decreased cAMP
what are 5HT3 receptors important for
mediation of fast excitatory neurotransmission
what does LSD stand for
lysergic acid diethylamide
LSD simple pharmacology
agonist of many 5HT receptors and also some dopamine receptors
most important = agonist of 5-HT2A
half life of LSD
long
175 minutes
effects last for 12 hours
psychedelic in magic mushrooms
psilocybin
3 monoamine neurotransmitters
serotonin
dopamine
norepinephrine
most common psychostimulant
MDMA/ecstacy
2 other psychostimulants
cocaine
amphetamine
which 5-HT receptors use Gq signalling
5-HT2A
5-HT2B
5-HT2C
where are 5-HT2A receptors found
dendrites in cortical areas
when are 5-HT2B important
during development
where are 5-HT2C receptors found
mesolimbic dopaminergic pathway (VTA) and amygdulla
which 5-HT receptors couple via Gas
5-HT4
5-HT6
5-HT7
where are 5-HT4 receptors found
substantia nigra
hippocampus
basal ganglia
cortex
where are 5-HT6 receptors found
almost exclusively in CNS
where are 5-HT7 receptors found
hypothalamus
thalamus
cortex
hippocampus
which 5-HT receptors couple via Gi/o
5-HT1A,B,D,E,F
5-HT5A,B
LSD derived from
cereal fungus, ergot
main effects of LSD
pupil dilation hallucinations strong emotions --> euphoria spirituality awakefulness loss of apetite
binding affinity of LSD
very high
2.7nM –> ki is very small
LSD has much lower binding affinity for which receptor subtype
5-HT6
half life of psilocybin
shorter than LSD
2 hours
effects last 4-5 hours
side effects of psilocybin
panic attacks
vomiting
first pass metabolism of psilocybin
converted to psilocin
much more potent
potential clinical uses for psilocybin
treatment of depression
alcohol addiction
effect of blocking 5-HT2A receptors on hallucinogens
no effects of hallucinogens
how many genes encode serotonin receptors
14
3 presynaptic monoamine transporter
NAT
DAT
SERT
feature of monoamine transporters
sodium coupled
transporters to load monoamines into vesicles
VMAT1 - peripherally
VMAT2
what do psychostimulants target
monoamine transporters
effects of MDMA
increased wakefulness, energy euphoria increased empathy, sociability increased senses bruxism (teeth clenching/grinding) elevated HR, BP addictive
pharmacology of MDMA
enters via monoamine transporters e.g. SERTs
inactivates VMATs
reverses SERTs –> dumps all the serotonin back into the synaptic cleft
clinical use of monoamine transporter antagonists
treatment of substance abuse
clinical use of monoamine transporter agonists
treatment of depression, ADHD, anxiety
how many different genes for dopamine receptors
5
structure of all dopamine receptors
GPCR
D1-like dopamine receptors
D1 and D5
Gs signalling
D2-like dopamine receptors
D2, D3, D4
Gi/o signalling
important dopamine target for antipsychotics
D2-like dopamine receptors
different levels of measuring a drugs avtivity
from molecular level, to tissue, to an entire animal to clinical trials etc.
in vitro assay to measure drug activity
radioactive labelled substrate for the receptor
filter through and wash and measure residual radioactivity
add other drug and see how much it displaces the radioactive-labelled drug
advantages of in vitro assays
cheap
reproducible
high throughput
can study single protein/receptor in isolation
disadvantages of in vitro assays
recombinant receptors do not always behave in the same way
cant measure active metabolites
cant measure pharmacokinetics e.g. how quickly drugs cleared
in vivo assay
measure effect of compound using whole animal
method of in vivo microdialysis
give little mouse MDMA stick probe in its brain pump perfusate into probe semi permeable membrane allows drug to pass into measure amount of drug every 20 mins
advantages of in vivo assays
allows measurement of effects without knowing mechanism
can measure pharmacokinetics
more physiological relevance
disadvantages of in vivo assays
doesnt determine mechanism
low throughput
uses whole animal (cost/ethics)
where does serotonin come from
raphe nuclei in the brain stem
projects throughout entire brain
where do norepinephrine projections arise from
locus coeruleus
potential neurotransmitter co-release mechanisms
more than one NT in the same vesicle
different vesicles releasing different NT
different pre-synaptic boutons
many neurons release both a classical NT as well as a
neuropeptide
e.g. somatostatin, ATP